Joachim Stangier

Boehringer Ingelheim (United States) · Boehringer Ingelheim (Germany)

2本站收录论文

36这些论文的被引

2本站 h 指数

12合作者

作者编号 A5002133662。统计只算本站收录的论文。

发表的论文2 篇，按出版时间

1
Idarucizumab, a specific reversal agent for dabigatran: mode of action, pharmacokinetics and pharmacodynamics, and safety and efficacy in phase 1 subjectsAmerican Journal of Emergency Medicine201628
2
INITIAL RESULTS OF THE RE-VERSE AD TRIAL: IDARUCIZUMAB REVERSES THE ANTICOAGULANT EFFECTS OF DABIGATRAN IN PATIENTS IN AN EMERGENCY SETTING OF MAJOR BLEEDING, URGENT SURGERY OR INTERVENTIONSEmergency Medicine Journal20158

按月发文

逐年被引

合作者

Paul A. Reilly2 篇 Stephan Glund2 篇 Jeffrey Ian Weitz1 篇 Chak Wah Kam1 篇 John W. Eikelboom1 篇 Elaine M. Hylek1 篇 Menno Volkert Huisman1 篇 Jerrold H. Levy1 篇 J. Kreuzer1 篇 Pieter Willem Kamphuisen1 篇 James Gagg1 篇 Charles V. Pollack1 篇

研究主题和期刊

Emergency Medicine Journal1 American Journal of Emergency Medicine1